Sort
48,018 grants matching “immunotherapy”
INHIBITION OF A TREG DEUBIQUITINASE, USP7, PROMOTES ANTI-TUMOR IMMUNITY
$369,220Wayne William Hancock · Children'S Hosp Of Philadelphia · R01 · FY2019 · CA
Bile acids restrict functional reprogramming of myeloid-derived suppressor cells in tumor beds
$369,216Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Characterizing oncogenic function of ITCH in melanoma
$369,216Lixin Wan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells
$369,216Jose Alejandro Guevara-Patino · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Characterizing oncogenic function of ITCH in melanoma
$369,216Lixin Wan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells
$369,216Jose Alejandro Guevara-Patino · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Bile acids restrict functional reprogramming of myeloid-derived suppressor cells in tumor beds
$369,216Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
ATR: targeting mechanical stress induced EMT and immune suppression in triple negative breast cancer
$369,203Robert W Mutter · Mayo Clinic Rochester · R01 · FY2025 · CA
ATR: targeting mechanical stress induced EMT and immune suppression in triple negative breast cancer
$369,203Robert W Mutter · Mayo Clinic Rochester · R01 · FY2023 · CA
Damage Associated Molecular Patterns and Regenerative Failure in MS
$369,178Timothy Vartanian · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · NS
Proinflammatory T Regulatory Cells in Colon Cancer
$369,175Khashayarsha Khazaie · Northwestern University At Chicago · R01 · FY2013 · CA
RP-4: Immunologic Predictors of BCG Immunotherapy for Bladder Cancer
$369,155Michael Stephen Glickman · Sloan-Kettering Inst Can Research · P50 · FY2018 · CA
RP-3: Elucidating Mechanisms of Sensitivity and Resistance to Checkpoint Blockade Therapy for Rational Multi-Drug Immunotherapy in Urothelial Cancers
$369,155Timothy An-Thy Chan · Sloan-Kettering Inst Can Research · P50 · FY2018 · CA
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT HIV
$369,153Beth Israel Deaconess Medical Center · R01 · FY2003 · AI
Damage Associated Molecular Patterns and Regenerative Failure in MS
$369,144Timothy Vartanian · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · NS
Mechanisms of Arginine Deprivation in Small Cell Lung Cancer
$369,125Trudy Gale Oliver · University Of Utah · R01 · FY2021 · CA
Damage Associated Molecular Patterns and Regenerative Failure in MS
$369,109Timothy Vartanian · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · NS
Separating autoimmunity and anti-tumor immunity
$369,101Isabelle Caroline Le Poole · Northwestern University At Chicago · R01 · FY2017 · CA
Non-deletional CD8 T cell self-tolerance
$369,095Stephen C Jameson · University Of Minnesota · P01 · FY2021 · AI
Mechanisms Underlying the Role of Interleukin-7 in Type 1 Diabetes
$369,075Hans Peter Dooms · Boston University Medical Campus · R01 · FY2016 · DK
Damage Associated Molecular Patterns and Regenerative Failure in MS
$369,074Timothy Vartanian · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · NS
Role of hybrid peptide specific T cells in diabetes
$369,052Brian T Fife · University Of Minnesota · P01 · FY2021 · AI
ALTERING THE IMMUNE LANDSCAPE TO AUGMENT BONE REGENERATION
$369,050Daniel Alge · Texas Engineering Experiment Station · R21 · FY2023 · AR
Osteoimmunology Core
$369,041Benjamin L Miller · University Of Rochester · P50 · FY2024 · AR
Mechanistic investigation of therapies for Down Syndrome Regression Disorder
$369,021Joaquin M. Espinosa · University Of Colorado Denver · R61 · FY2022 · HD